Gestational surrogacy in the Czech Republic.


Journal

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
ISSN: 1804-7521
Titre abrégé: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
Pays: Czech Republic
ID NLM: 101140142

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 20 04 2018
accepted: 12 07 2018
pubmed: 22 9 2018
medline: 8 1 2020
entrez: 22 9 2018
Statut: ppublish

Résumé

Gestational surrogacy, is a treatment option for women with certain clearly defined medical problems, usually an absent uterus, to help them have their own genetic children. The aim of our study was to review, evaluate and share our experience and outcomes over the last 13 years of the largest surrogacy program in the Czech republic. A total of 75 intended mothers and 82 surrogate mothers participated in this study. A retrospective cohort study was performed. Anonymized data were collected on 130 cycles of gestational surrogate (2004-2017) directly from the Clinic database. We performed 130 in vitro fertilization cycles with gestational surrogacy which involved 73 fresh embryo transfers and 57 frozen embryo transfers. We achieved 57 (43.9%) pregnancies and 42 (32.3%) live births. The rate of multiple pregnancies was only 2.3 %. The most common indication for using was an absent or damaged uterus (65%), followed by medical conditions precluding pregnancy (23%) and repeated in vitro fertilization cycles or pregnancy failure (12%). In the 14 years of our experience, we have shown that treatment of young women with specific indications for gestational surrogacy is beneficial, successful and relatively free of complications. However, it is imperative to follow the medical indications for this treatment and specialist recommendations.

Sections du résumé

BACKGROUND BACKGROUND
Gestational surrogacy, is a treatment option for women with certain clearly defined medical problems, usually an absent uterus, to help them have their own genetic children. The aim of our study was to review, evaluate and share our experience and outcomes over the last 13 years of the largest surrogacy program in the Czech republic.
METHODS METHODS
A total of 75 intended mothers and 82 surrogate mothers participated in this study. A retrospective cohort study was performed. Anonymized data were collected on 130 cycles of gestational surrogate (2004-2017) directly from the Clinic database.
RESULTS RESULTS
We performed 130 in vitro fertilization cycles with gestational surrogacy which involved 73 fresh embryo transfers and 57 frozen embryo transfers. We achieved 57 (43.9%) pregnancies and 42 (32.3%) live births. The rate of multiple pregnancies was only 2.3 %. The most common indication for using was an absent or damaged uterus (65%), followed by medical conditions precluding pregnancy (23%) and repeated in vitro fertilization cycles or pregnancy failure (12%).
CONCLUSION CONCLUSIONS
In the 14 years of our experience, we have shown that treatment of young women with specific indications for gestational surrogacy is beneficial, successful and relatively free of complications. However, it is imperative to follow the medical indications for this treatment and specialist recommendations.

Identifiants

pubmed: 30238935
doi: 10.5507/bp.2018.040
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

155-160

Auteurs

David Rumpik (D)

Clinic of Reproductive Medicine and Gynecology Zlin, Zlin, Czech Republic.
Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, Masaryk University Brno, Brno, Czech Republic.

Tatana Rumpikova (T)

Clinic of Reproductive Medicine and Gynecology Zlin, Zlin, Czech Republic.
Faculty of Humanities, Bata University Zlin, Zlin, Czech Republic.

Michal Pohanka (M)

Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, Masaryk University Brno, Brno, Czech Republic.

Pavel Ventruba (P)

Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, Masaryk University Brno, Brno, Czech Republic.

Silvie Belaskova (S)

International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic Corresponding author: David Rumpik, e-mail.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH